Your browser doesn't support javascript.
loading
[Single center experience of (18F)-fluorocholine positron emission tomography: analysis of its impact on salvage local therapy in patients with prostate adenocarcinoma]. / Expérience monocentrique de la tomographie par émission de positons à la (18F)-fluorocholine : analyse de son impact sur les indications de traitement local de rattrapage dans la prise en charge des adénocarcinomes prostatiques.
Moussaid, Y; Bonardel, G; Jacob, J; Métivier, D; Gontier, E; Bauduceau, O; Durand, X; Fayolle, M; Houlgatte, A; Foehrenbach, H; Védrine, L; Chargari, C.
Afiliación
  • Moussaid Y; Service d'Oncologie Radiothérapie, Hôpital d'Instruction des Armées du Val-de-Grâce, 74 boulevard de Port-Royal, 75005 Paris, France.
Cancer Radiother ; 17(4): 259-64, 2013.
Article en Fr | MEDLINE | ID: mdl-23702489
PURPOSE: To assess usefulness of ((18)F)-fluorocholine positron emission tomography (PET) for localizing relapse in patients with biochemical relapse from prostate adenocarcinoma and its impact on indications of salvage local therapy. PATIENTS AND METHODS: An ((18)F)-fluorocholine PET coupled with computed tomography was performed in 28 patients with biochemical progression from prostate adenocarcinoma. At the time of ((18)F)-fluorocholine PET, median prostate specific antigen (PSA) was 3.0 ng/mL (from 0.34 to 93 ng/mL) and 17 patients (60.7%) received hormone therapy. Eighteen patients from this cohort were potentially candidates to salvage radiotherapy. RESULTS: A pathologic uptake was shown in 11 patients (39.3%) and 17 patients (60.7%) had no pathologic uptake. Median PSA was 2.4 ng/mL (0.33 to 36 ng/mL) in case of negative ((18)F)-fluorocholine PET, versus 6.75 ng/mL (1.21 to 93 ng/mL) in case of pathologic uptake (P=0.04). Among the 17 patients candidates to salvage radiotherapy, ((18)F)-fluorocholine PET helped deciding for salvage radiotherapy in five patients, since it showed only centropelvic pathologic uptake (27.7%). In one patient, it showed metastatic and radiotherapy was contraindicated. After prostatectomy, ((18)F)-fluorocholine PET was positive in only one patient candidate to salvage radiotherapy (9.1%), showing anastomotic relapse. CONCLUSION: ((18)F)-fluorocholine was positive in about a third of patients with biochemical progression. Its clinical impact is being prospectively investigated.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Radioisótopos de Flúor / Adenocarcinoma / Colina / Terapia Recuperativa / Radiofármacos / Tomografía de Emisión de Positrones / Recurrencia Local de Neoplasia Tipo de estudio: Evaluation_studies / Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: Fr Revista: Cancer Radiother Asunto de la revista: NEOPLASIAS / RADIOTERAPIA Año: 2013 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Radioisótopos de Flúor / Adenocarcinoma / Colina / Terapia Recuperativa / Radiofármacos / Tomografía de Emisión de Positrones / Recurrencia Local de Neoplasia Tipo de estudio: Evaluation_studies / Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Humans / Male / Middle aged Idioma: Fr Revista: Cancer Radiother Asunto de la revista: NEOPLASIAS / RADIOTERAPIA Año: 2013 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Francia